mRNA |
elocalcitol |
CTRPv2 |
pan-cancer |
AAC |
-0.033 |
0.3 |
mRNA |
Compound 23 citrate |
CTRPv2 |
pan-cancer |
AAC |
-0.033 |
0.3 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.033 |
0.3 |
mRNA |
pifithrin-mu |
CTRPv2 |
pan-cancer |
AAC |
-0.034 |
0.3 |
mRNA |
austocystin d |
CTRPv2 |
pan-cancer |
AAC |
0.036 |
0.3 |
mRNA |
Rapamycin |
CTRPv2 |
pan-cancer |
AAC |
0.033 |
0.3 |
mRNA |
Fumonisin B1 |
CTRPv2 |
pan-cancer |
AAC |
-0.035 |
0.3 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.033 |
0.3 |
mRNA |
L-685458 |
CCLE |
pan-cancer |
AAC |
-0.043 |
0.3 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.033 |
0.3 |